Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 468271016 | Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 468272011 | Sodium cromoglycate compound 2% nasal spray | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 721083011 | Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module | 
| 1192367012 | Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray (product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3693959012 | Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module | 
| 3693960019 | Cromolyn sodium 20 mg/mL and xylometazoline hydrochloride 250 microgram/mL nasal spray | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module | 
| 3693961015 | Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module | 
| 3782389016 | Sodium cromoglicate 20 mg/mL and xylometazoline hydrochloride 250 microgram/mL nasal spray | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module | 
| 46758501000001115 | Sodium cromoglicate 2% / Xylometazoline 0.025% nasal spray | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Is a | Product containing sodium cromoglycate in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Substance with mast cell stabilizer mechanism of action (substance) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Cromoglicate sodium | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Is a | Sodium cromoglycate+xylometazoline hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Xylometazoline hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Bronchodilator | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Analgesic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Anti-inflammatory agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Nasal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Is a | Product containing cromoglicic acid in nasal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Is a | Product containing xylometazoline in nasal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has precise active ingredient | Xylometazoline hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength numerator unit | microgram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has basis of strength substance | Xylometazoline hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has basis of strength substance | Cromoglicate sodium | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has precise active ingredient | Cromoglicate sodium | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Is a | Product containing only cromoglicic acid and xylometazoline in nasal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has precise active ingredient | Xylometazoline hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has precise active ingredient | Cromoglicate sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has basis of strength substance | Xylometazoline hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has basis of strength substance | Cromoglicate sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Cromoglicate sodium | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Nasal route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutionspray.nasal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Cromoglicic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Xylometazoline | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Nasal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Conventional release nasal spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has active ingredient | Sodium cromoglicate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has specific active ingredient | Xylometazoline hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has specific active ingredient | Cromoglicate sodium | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has dispensed dose form | Spray dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Is a | Sodium cromoglicate + Xylometazoline | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Has manufactured dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Sodium cromoglycate+xylometazoline hydrochloride 2%/0.025% nasal spray | Is a | False | Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Inferred relationship | Existential restriction modifier | |
| Rynacrom Allergy nasal spray (Aventis Pharma) | Is a | True | Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Inferred relationship | Existential restriction modifier | |
| Sodium cromoglicate 2% / Xylometazoline 0.025% nasal spray 10 ml | Is pack of | False | Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Inferred relationship | Existential restriction modifier | |
| Sodium cromoglicate 2% / Xylometazoline 0.025% nasal spray 10 ml | Has VMP | True | Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray | Inferred relationship | Existential restriction modifier | 
This concept is not in any reference sets